PET
PET is a pharmaceutical drug with 46 clinical trials. Currently 6 active trials ongoing. Historical success rate of 82.1%.
Success Metrics
Based on 23 completed trials
Phase Distribution
Phase Distribution
12
Early Stage
8
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
76.7%
23 of 30 finished
23.3%
7 ended early
6
trials recruiting
46
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients
HER2-PET: Predicting T-DXd Efficacy and HER2 Heterogeneity
MARINER Trial: Multiparametric Cardiac PET for CAV Surveillance After Heart Transplantation
EQUIP - Evaluation of Quality of Imaging on a Next-generation Total Body Pet Scan in Comparison to Conventional PET
Clinical Trials (46)
Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients
HER2-PET: Predicting T-DXd Efficacy and HER2 Heterogeneity
MARINER Trial: Multiparametric Cardiac PET for CAV Surveillance After Heart Transplantation
EQUIP - Evaluation of Quality of Imaging on a Next-generation Total Body Pet Scan in Comparison to Conventional PET
[18F] - FD17 PET Imaging of α-synuclein: A Clinical Study in α-synucleinopathy Patients
Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies
Radialis PET Imager for the Assessment of Neuritic Amyloid Plaque Burden
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (VIPOR) for Diffuse Large B-cell Lymphoma Involving the Central Nervous System
Examination of Glutamate and mGluR5 in Psychiatric Disorders
Compensatory Mechanisms in Parkinson Disease (PD)
T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers
[18F] LBT-999 PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkinson's Diseases and Essential Tremor
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
Follow-up of Patients With Curative-intent Surgical Resection for NSCLC
Predictive Value of PET/CT for Efficacy of Neoadjuvant Immunotherapy in Non-small Cell Lung Cancer
Tau PET Imaging in Atypical Dementias
FAPI PET/CT to Detect Fibroblast Activity in Non-resolving ARDS
Florbetaben PET Imaging in PPA
Test of Reproducibility of [15O]H20-PET Assessment of Brain Perfusion
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 46